| Ditemukan 1294 dokumen dengan kata kunci 6396 |
Simpan CSV  |
|
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
|
|
|
|
Shiftwork and Prostate-Specific Antigen in the National Health and Nutrition Examination Survey
|
| No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.17, 4 September 2013: p.1292-1297 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human am integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer
|
|
|
|
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer†
|
|
|
|
Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensivedisease- small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial
|
|
|
|
Targeting Amino Acid Transport in Metastatic Castration- Resistant Prostate Cancer: Effects on Cell Cycle, Cell Growth, and Tumor Development
|
| No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.19, 2 October 2013: p.1463-1473 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Men Treated With Second-Line Chemotherapy
|
| No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.22, 20 November 2013: p.1729-1737 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II
|
|
|
|
Open-label, phase II study of routine high-flow nasal oxygen therapy in cardiac surgical patients
|
|
|
|
Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer
|
|
|
Hasil Pencarian
